Avai Bio (AVAI) Capital Expenditures (2019 - 2021)

Avai Bio has disclosed Capital Expenditures across 3 years of filings, most recently posting -$122817.0 for Q1 2021.

• Capital Expenditures for Q1 2021 came in at -$122817.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $114.0 (changed N/A YoY), and the FY2021 annual result was $114.0, changed N/A from the prior year.
• Capital Expenditures came in at -$122817.0 for Q1 2021 at Avai Bio, down from $122550.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $122550.0 in Q4 2020 to a low of -$122817.0 in Q1 2021.
• The 3-year median for Capital Expenditures is $601.0 (2020), against an average of $5190.4.